Bruker’s (NASDAQ:BRKR) Q1 CY2026: Strong Sales
Q1 2026 revenues of $823.4 million, up 2.7% year-over-year (yoy), down 4.4% organically Q1-26 GAAP diluted earnings per share (EPS) $0.02; non-GAAP diluted...
Barchart Research What to Expect from BRKR Earnings BRKR Generated May 5, 2026 Current Price $38.01 EPS Estimate $$0.23 Consensus Rating Moderate Buy Average Move 5.24% Bruker's Earnings Call Tomorrow...
Bruker (BRKR) Q1 Earnings Report Preview: What To Look For
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and...
3 Healthcare Stocks That Fall Short
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
Bruker Spatial Biology features new GeoMx-to-CellScape and CellScape-to-CosMx cross-platform workflows and first-of-its-kind 208-plex CellScape XR spatial proteomics datasets
At ESCMID Global 2026 , the Bruker Microbiology & Infection Diagnostics division ( Bruker Corporation , Nasdaq: BRKR) announces the European launch of MyGenius...